A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Zobair M. Younossi, Abhijit Chowdhury et al.|Hepatology|2023Cited by 2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Zobair M. Younossi, Jeffrey V. Lazarus et al.|Journal of Hepatology|2023Cited by 2.7k
Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscleKenneth Cusi, Lawrence J. Mandarino|Journal of Clinical Investigation|2000Cited by 1.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Zobair M. Younossi, Jeffrey V. Lazarus et al.|Annals of Hepatology|2023Cited by 789
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver DiseaseFasiha Kanwal, Kenneth Cusi, Jay H. Shubrook et al.|Gastroenterology|2021Cited by 577